PhysioSonics has received a $2.5m grant from the Telemedicine and Advanced Technology Research Center (TATRC) to optimise its proprietary cerebral blood-flow monitor to detect vasospasm.
The blood-flow monitor can automatically identify the mid-cerebral artery and provide a continuous measurement of the blood's flow and peak velocity.
The recently completed clinical study demonstrated that the blood flow monitor showed parity with transcranial Doppler ultrasound.
PhysioSonics CEO Brad Harlow said that the blood-flow monitor can help physicians to accurately monitor for vasospasm among soldiers injured by a blast from an improvised explosive device or other traumatic explosion.
Following launch, the military will test the blood-flow monitor with the aim of installing it at military facilities that care for soldiers with traumatic brain injuries.
The company plans to file a 510k application for the blood-flow monitor with the US Food and Drug Administration.